ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis says Entresto outperforms heart failure drug enalapril in key study
November 13, 2018Novartis presented study data at the American Heart Association's (AHA) scientific sessions showing that Entresto (sacubitril/valsartan) outperformed enalapril in patients with heart failure with reduced ejection fraction requiring hospitalisation for an -
Novartis says Entresto outperforms heart failure drug enalapril in key study
November 13, 2018Novartis presented study data at the American Heart Association's (AHA) scientific sessions showing that Entresto (sacubitril/valsartan) outperformed enalapril in patients with heart failure with reduced ejection fraction requiring hospitalisation for an
Pharma Sources Insight January 2025
